Scientific paper - Original scientific paper
Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia
Blood Cancer Journal, 12 (2022), 4; 71. https://doi.org/10.1038/s41408-022-00668-8

Pratz, Keith W.; Panayiotidis, Panayiotis; Recher, Christian; Wei, Xudong; Jonas, Brian A.; Montesinos, Pau; Ivanov, Vladimir; Schuh, Andre C.; DiNardo, Courtney D.; Novak, Jan; Pejša, Vlatko; Stevens, Don; Yeh, Su-Peng; Kim, Inho; Turgut, Mehmet; Fracchiolla, Nicola; Yamamoto, Kazuhito; Ofran, Yishai; Wei, Andrew H.; Bui, Cat N.; Benjamin, Katy; Kamalakar, Rajesh; Potluri, Jalaja; Mendes, Wellington; Devine, Jacob; Fiedler, Walter More authors...

Cite this document

Pratz, K. W., Panayiotidis, P., Recher, C., Wei, X., Jonas, B. A., Montesinos, P. ... Fiedler, W. (2022). Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia. Blood Cancer Journal, 12. (4). doi: 10.1038/s41408-022-00668-8

Pratz, Keith W., et al. "Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia." Blood Cancer Journal, vol. 12, no. 4, 2022. https://doi.org/10.1038/s41408-022-00668-8

Pratz, Keith W., Panayiotis Panayiotidis, Christian Recher, Xudong Wei, Brian A. Jonas, Pau Montesinos, Vladimir Ivanov, et al. "Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia." Blood Cancer Journal 12, no. 4 (2022). https://doi.org/10.1038/s41408-022-00668-8

Pratz, K. W., et al. (2022) 'Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia', Blood Cancer Journal, 12(4). doi: 10.1038/s41408-022-00668-8

Pratz KW, Panayiotidis P, Recher C, Wei X, Jonas BA, Montesinos P, and sur.. Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia. Blood Cancer Journal [Internet]. 2022 April 20 [cited 2024 October 14];12(4). doi: 10.1038/s41408-022-00668-8

K. W. Pratz, et al., "Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia", Blood Cancer Journal, vol. 12, no. 4, April 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:795165. [Accessed: 14 October 2024]